Alfred L. Williams
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alfred L. Williams has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Srinivasa Reddy Dandepally
Biomanufacturing Research Institute and Technology Enterprise (BRITE), North Carolina Central University, Durham, North Carolina 27707, United States
2 shared publications Valentine R. St. Hilaire
Biomanufacturing Research Institute and Technology Enterprise (BRITE), North Carolina Central University, Durham, North Carolina 27707, United States
2 shared publicationsAlisha R. Yallowitz
Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, 10065, USA
1 shared publicationBing Su
Department of Immunology and Microbiology, and the Minister of Education Key Laboratory of Cell Death and Differentiation, Shanghai Institute of Immunology, Shanghai JiaoTong University School of Medicine, 200025, Shanghai, China
1 shared publicationDong Yeon Shin
Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, 10065, USA
1 shared publication- Jae-Hyuck Shim
Department of Genetic and Cellular Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA
1 shared publication
Latest Publications
- Open Access
- 11 November 2020
- Published by Springer Nature in Nature Communications
- Vol. 11 (1) , 1-10
MEKK2 mediates aberrant ERK activation in neurofibromatosis type I
Neurofibromatosis type I (NF1) is characterized by prominent skeletal manifestations caused by NF1 loss. While inhibitors of the ERK activating kinases MEK1/2 are promising as a means to treat NF1, the broad blockade of the ERK pathway produced by this strategy is potentially associated with therapy limiting toxicities. Here, we have sought targets offering a more narrow inhibition of ERK activation downstream of NF1 loss in the skeleton, finding that MEKK2 is a novel component of a noncanonical ERK pathway in osteoblasts that mediates aberrant ERK activation after NF1 loss. Accordingly, despite mice with conditional deletion of Nf1 in mature osteoblasts (Nf1fl/fl;Dmp1-Cre) and Mekk2−/− each displaying skeletal defects, Nf1fl/fl;Mekk2−/−;Dmp1-Cre mice show an amelioration of NF1-associated phenotypes. We also provide proof-of-principle that FDA-approved inhibitors with activity against MEKK2 can ameliorate NF1 skeletal pathology. Thus, MEKK2 functions as a MAP3K in the ERK pathway in osteoblasts, offering a potential new therapeutic strategy for the treatment of NF1.
- 11 November 2020
- Published by Springer Nature in Nature Communications
- Vol. 11 (1) , 1-10
Open AccessMEKK2 mediates aberrant ERK activation in neurofibromatosis type I
Neurofibromatosis type I (NF1) is characterized by prominent skeletal manifestations caused by NF1 loss. While inhibitors of the ERK activating kinases MEK1/2 are promising as a means to treat NF1, the broad blockade of the ERK pathway produced by this strategy is potentially associated with therapy limiting toxicities. Here, we have sought targets offering a more narrow inhibition of ERK activation downstream of NF1 loss in the skeleton, finding that MEKK2 is a novel component of a noncanonical ERK pathway in osteoblasts that mediates aberrant ERK activation after NF1 loss. Accordingly, despite mice with conditional deletion of Nf1 in mature osteoblasts (Nf1fl/fl;Dmp1-Cre) and Mekk2−/− each displaying skeletal defects, Nf1fl/fl;Mekk2−/−;Dmp1-Cre mice show an amelioration of NF1-associated phenotypes. We also provide proof-of-principle that FDA-approved inhibitors with activity against MEKK2 can ameliorate NF1 skeletal pathology. Thus, MEKK2 functions as a MAP3K in the ERK pathway in osteoblasts, offering a potential new therapeutic strategy for the treatment of NF1.
- Open Access
- 8 January 2019
- Published by Beilstein Institut in Beilstein Journal of Organic Chemistry
- Vol. 15 (1) , 72-78
Regioselective addition of Grignard reagents to N-acylpyrazinium salts: synthesis of substituted 1,2-dihydropyrazines and Δ5-2-oxopiperazines
The regioselective addition of Grignard reagents to mono- and disubstituted N-acylpyrazinium salts affording substituted 1,2-dihydropyrazines in modest to excellent yields (45–100%) is described. Under acidic conditions, these 1,2-dihydropyrazines can be converted to substituted Δ5-2-oxopiperazines providing a simple and efficient approach towards their preparation.
- 8 January 2019
- Published by Beilstein Institut in Beilstein Journal of Organic Chemistry
- Vol. 15 (1) , 72-78
Open AccessRegioselective addition of Grignard reagents to N-acylpyrazinium salts: synthesis of substituted 1,2-dihydropyrazines and Δ5-2-oxopiperazines
The regioselective addition of Grignard reagents to mono- and disubstituted N-acylpyrazinium salts affording substituted 1,2-dihydropyrazines in modest to excellent yields (45–100%) is described. Under acidic conditions, these 1,2-dihydropyrazines can be converted to substituted Δ5-2-oxopiperazines providing a simple and efficient approach towards their preparation.
- 9 March 2012
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 77 (8) , 4097-4102
Regioselective Reduction of 3-Substituted N-Acylpyrazinium Salts toward the Synthesis of 1,2-Dihydropyrazines
The regioselective reduction of 3-substituted N-acylpyrazinium salts with n-Bu3SnH has been developed for the synthesis of 3-substituted 1,2-dihydropyrazines in yields of 56–94%. Substitution of the pyrazinium salts with electron-donating groups favors the formation of the 1,2-isomers as a result of their better stability over the 1,6-isomers. Under mild acidic conditions, 3-methoxy substituted 1,2-dihydropyrazine was easily hydrolyzed in excellent yield to Δ5-2-oxopiperazine.
- 9 March 2012
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 77 (8) , 4097-4102
Regioselective Reduction of 3-Substituted N-Acylpyrazinium Salts toward the Synthesis of 1,2-Dihydropyrazines
The regioselective reduction of 3-substituted N-acylpyrazinium salts with n-Bu3SnH has been developed for the synthesis of 3-substituted 1,2-dihydropyrazines in yields of 56–94%. Substitution of the pyrazinium salts with electron-donating groups favors the formation of the 1,2-isomers as a result of their better stability over the 1,6-isomers. Under mild acidic conditions, 3-methoxy substituted 1,2-dihydropyrazine was easily hydrolyzed in excellent yield to Δ5-2-oxopiperazine.
- 21 November 2009
- Published by Springer Nature in Molecular Diversity
- Vol. 14 (4) , 697-707
A p-methoxybenzyl (PMB) protection/deprotection approach toward the synthesis of 5-phenoxy-4-chloro-N-(aryl/alkyl) thiophene-2-sulfonamides
The synthesis of 17 phenoxy substituted 4-chloro-N-(aryl/alkyl)thiophene-2-sulfonamides using a PMB protection/deprotection strategy is described. Nucleophilic displacement of p-methoxybenzyl (PMB) protected 4,5-dichloro-N-(aryl/alkyl)-thiophene-2-sulfonamides was carried out with different phenols under mild basic conditions. Reaction times of 3–6 h and overall yields of 78–98% were achieved with the PMB group in place compared to no reaction without this protecting group. The PMB group was easily and selectively removed in 68–98% yield using TFA in DCM.
- 21 November 2009
- Published by Springer Nature in Molecular Diversity
- Vol. 14 (4) , 697-707
A p-methoxybenzyl (PMB) protection/deprotection approach toward the synthesis of 5-phenoxy-4-chloro-N-(aryl/alkyl) thiophene-2-sulfonamides
The synthesis of 17 phenoxy substituted 4-chloro-N-(aryl/alkyl)thiophene-2-sulfonamides using a PMB protection/deprotection strategy is described. Nucleophilic displacement of p-methoxybenzyl (PMB) protected 4,5-dichloro-N-(aryl/alkyl)-thiophene-2-sulfonamides was carried out with different phenols under mild basic conditions. Reaction times of 3–6 h and overall yields of 78–98% were achieved with the PMB group in place compared to no reaction without this protecting group. The PMB group was easily and selectively removed in 68–98% yield using TFA in DCM.
- 1 March 2009
- Published by Elsevier in Tetrahedron Letters
- Vol. 50 (9) , 1071-1074
Microwave-assisted N-Boc deprotection under mild basic conditions using K3PO4·H2O in MeOH
- 1 March 2009
- Published by Elsevier in Tetrahedron Letters
- Vol. 50 (9) , 1071-1074
Microwave-assisted N-Boc deprotection under mild basic conditions using K3PO4·H2O in MeOH